AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
28.29
-0.53 (-1.84%)
May 22, 2026, 4:00 PM EDT - Market closed
AtriCure Revenue
AtriCure had revenue of $141.25M in the quarter ending March 31, 2026, with 14.26% growth. This brings the company's revenue in the last twelve months to $552.16M, up 15.01% year-over-year. In the year 2025, AtriCure had annual revenue of $534.53M with 14.88% growth.
Revenue (ttm)
$552.16M
Revenue Growth
+15.01%
P/S Ratio
2.59
Revenue / Employee
$409,005
Employees
1,350
Market Cap
1.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 534.53M | 69.22M | 14.88% |
| Dec 31, 2024 | 465.31M | 66.06M | 16.55% |
| Dec 31, 2023 | 399.25M | 68.87M | 20.84% |
| Dec 31, 2022 | 330.38M | 56.05M | 20.43% |
| Dec 31, 2021 | 274.33M | 67.80M | 32.83% |
| Dec 31, 2020 | 206.53M | -24.28M | -10.52% |
| Dec 31, 2019 | 230.81M | 29.18M | 14.47% |
| Dec 31, 2018 | 201.63M | 26.91M | 15.40% |
| Dec 31, 2017 | 174.72M | 19.61M | 12.64% |
| Dec 31, 2016 | 155.11M | 25.35M | 19.54% |
| Dec 31, 2015 | 129.76M | 22.30M | 20.75% |
| Dec 31, 2014 | 107.45M | 25.57M | 31.22% |
| Dec 31, 2013 | 81.89M | 11.64M | 16.57% |
| Dec 31, 2012 | 70.25M | 5.85M | 9.08% |
| Dec 31, 2011 | 64.40M | 5.40M | 9.14% |
| Dec 31, 2010 | 59.01M | 4.47M | 8.20% |
| Dec 31, 2009 | 54.53M | -723.40K | -1.31% |
| Dec 31, 2008 | 55.26M | 6.95M | 14.38% |
| Dec 31, 2007 | 48.31M | 10.07M | 26.32% |
| Dec 31, 2006 | 38.24M | 7.29M | 23.54% |
| Dec 31, 2005 | 30.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| Warby Parker | 890.57M |
| Azenta | 596.48M |
| STAAR Surgical Company | 290.38M |
| LeMaitre Vascular | 256.28M |
| BioLife Solutions | 101.66M |
| Alamar Biosciences | 87.16M |
| Kestra Medical Technologies | 83.72M |
ATRC News
- 6 days ago - AtriCure Transcript: AGM 2026 - Transcripts
- 11 days ago - AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook - MarketBeat
- 11 days ago - AtriCure Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 17 days ago - AtriCure price target raised to $55 from $53 at Canaccord - TheFly
- 17 days ago - AtriCure participates in a conference call with JPMorgan - TheFly
- 18 days ago - AtriCure Earnings Call Transcript: Q1 2026 - Transcripts
- 18 days ago - AtriCure Earnings release: Q1 2026 - Filings
- 18 days ago - AtriCure Quarterly report: Q1 2026 - Filings